Union Bank, Wockhardt Shift to Bullish Momentum

In a period where the broader NSE market, as indicated by the Altra Market score, presents a 'Mixed' picture at 52.6, individual stock momentum signals can offer valuable insights. The Altra Market score assesses overall market breadth by looking at the percentage of stocks trading above key Exponential Moving Averages (EMAs), offering a read on the market's underlying texture. Despite a cautious market sentiment reflected in breadth data—with only 50% of stocks above their 20-day and 200-day EMAs and a negative 15-day score trend—two distinct stocks recently shifted into bullish momentum territory, cutting across different sectors. This points to potential opportunities where company-specific strength may be overcoming broader market headwinds. The Altra Score is a 0-100 momentum rating for individual stocks, derived from the alignment of EMAs and the Relative Strength Index (RSI) across daily, weekly, and monthly timeframes. A higher score indicates stronger bullish momentum.

Union Bank of India (UNIONBANK)

Union Bank of India experienced a significant surge in its individual momentum, with its Altra Score jumping from 55.2 (Neutral) to a robust 93.2 (Strong Bullish) on July 13, 2026. This dramatic shift places UNIONBANK firmly in a high-momentum phase, driven by favorable EMA placement where the stock is trading above its key EMAs across multiple timeframes. The Relative Strength Index (RSI) for the daily and weekly charts sits around 53.6 and 51.46 respectively, indicating a relatively neutral to slightly stronger short-term sentiment, while the monthly RSI at 61.3 suggests more sustained buying interest over a longer horizon.

This individual strength emerges even as its parent sector, the Nifty Bank Sector, holds a 'bullish' Altra Sector score of 59.0, ranking second among NSE sectors. The Altra Sector score applies this same logic to entire sectors, providing a momentum read and a relative-strength rank against other sectors within the same market. However, the Nifty Bank Sector's regime is described as a 'Confirmed leader, cooling off', with its 4-week relative strength trend showing a slight decline (-0.72) and an RS RSI of 61.9. This suggests that while the sector has been strong, its momentum might be consolidating.

Despite the strong Altra Score for UNIONBANK, a notable point of divergence is the presence of a bearish Weekly EMA Crossover observed on July 6, 2026. This specific technical signal, where a shorter-term EMA crosses below a longer-term one on the weekly chart, typically indicates a potential loss of upward momentum or a short-term correction. This likely contributes to UNIONBANK's 'top-down aligned: False' status, implying that while the stock itself shows strong momentum, it isn't fully in sync with broader market or sector alignment. Given the overall 'Mixed' Altra Market score and the call to 'consider reducing position size' due to a negative 15-day market score trend and more declines than advances (22/28), traders and investors might observe UNIONBANK's sustained strength within this nuanced context.

Wockhardt Ltd. (WOCKPHARMA)

In the pharmaceutical space, Wockhardt Ltd. also showed a significant positive shift in momentum, with its Altra Score climbing from 43.7 (Neutral) to 64.0 (Bullish) on July 13, 2026. This move into bullish territory indicates an improving technical picture for WOCKPHARMA. The stock is currently trading above its key Exponential Moving Averages, supporting the strengthening momentum. Looking at the Relative Strength Index, the daily RSI is at 46.83, suggesting some recent consolidation or slight weakness, but the weekly and monthly RSIs are at 61.3 and 60.04 respectively, highlighting more robust underlying momentum over medium to longer timeframes.

Crucially, WOCKPHARMA benefits from a very strong sector backdrop. The Nifty Pharma Sector boasts an exceptional 'bullish' Altra Sector score of 92.0, making it the #1 ranked sector on the NSE. Furthermore, the Nifty Pharma Sector’s regime is characterized as a 'Confirmed leader, accelerating', with its 4-week relative strength trend showing a healthy increase (+2.96) and a strong RS RSI of 71.6. This indicates that the sector itself is exhibiting strong, increasing momentum, providing a supportive environment for stocks like WOCKPHARMA.

Adding to its bullish indicators, WOCKPHARMA registered a bullish Weekly EMA Crossover earlier, on May 8, 2026. This technical event, where a shorter-term EMA crosses above a longer-term one on the weekly chart, often signals the start or continuation of an upward trend. Despite these positive internal and sector-level signals, WOCKPHARMA also registers as 'top-down aligned: False'. This status, mirroring the situation with Union Bank, likely stems from the broader NSE market’s 'Mixed' Altra Market score and its cautious indicators, including the negative 15-day score trend and the slight majority of declining stocks. Investors might view WOCKPHARMA's bullish turn as a compelling individual setup, fortified by its leading sector, even while maintaining awareness of the broader market's nuanced signals.

What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.

Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.

Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.